Isosorbide Dinitrate NDC 68682-193

NDC codes

FDA NDC Directory

Product NDC (as listed)68682-193Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68682-0193Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68682-193-01	68682019301	100 TABLET in 1 BOTTLE (68682-193-01)Marketed from Mar 2, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Isosorbide Dinitrate
Generic name (nonproprietary): isosorbide dinitrate
Active ingredients: Isosorbide dinitrate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Oceanside Pharmaceuticals
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 012093
Marketing start: Mar 2, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Nitrates (Chemical structure)Vasodilation (Physiologic effect)
Identifiers: Product ID 68682-193_723d9f78-9d77-4575-af27-1aa117e6b8d7SPL ID 723d9f78-9d77-4575-af27-1aa117e6b8d7SPL set ID 723d9f78-9d77-4575-af27-1aa117e6b8d7RxCUI 197840, 314055UNII IA7306519NUPC 0368682193015
Pharmacologic class: Nitrate Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468682019301 followed by a unit qualifier and the quantity

Package 68682-0193-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 2, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Isosorbide Dinitrate tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)